Portfolio

Background on the Funds

 

OTAF I:  

  • Launched in 2004
  • 98 members
  • Invested in 16 companies
  • 3 lucrative exits (HTP, ClearSaleing, and SageQuest)
  • 6 write-downs

OTAF II:

  • Launched in 2007
  • 98 members
  • Invested in 16 companies
  • 1 lucrative exit (Znode)
  • 3 write-downs

OTAF III:

  • Launched in late 2009
  • 98 members
  • Invested in 13 companies (to-date)
  • No realized investments

 

 

 

7signal offers an innovative hardware/software wireless quality assurance architecture designed to make healthcare and other mission-critical enterprise wireless LAN networks work – reliably.  The vendor-independent solution is easily installed as a monitoring layer on top of any existing WLAN to help ensure that all end-users (clinicians, medical records, and medical devices) stay connected.  Founded in Finland by former Nokia R&D managers in 2006, it recently reorganized as an Ohio-based company. (OTAF III)

AircraftLogs.com, is a Columbus-based aviation company, which has developed  a complete technology product suite aimed at both the owner flown and business aviation marketplace.  Founded in 2005, the company has made excellent progress in penetrating both of these markets, and is rapidly becoming a recognized industry leader.   The maintenance, flight department, expense management, financial reporting and tax solutions offered by AircraftLogs have been met with great enthusiasm in the marketplace, providing immediate growth opportunities for the company. 

AquaBlok Ltd., is a Toledo materials manufacturing company that has developed patented bentonite-based composite material technology which can address a wide range of water and chemical control applications in geotechnical, mining and environmental markets.  The product is a composite resembling small stones, which are composed of a dense aggregate core, bentonite clay or similar materials, and polymers.  AquaBlok particles expand when hydrated, creating a mass that transforms into a continuous and relatively soft body of material, which acts as an effective physical, hydraulic, and chemical barrier.

AssureRx LLC, is a Cincinnati-based company, that was founded in 2006 to license and commercialize pharmacogenetic technology from Cincinnati Children’s Hospital Medical Center and Mayo Clinic. The technology utilized in the AssureRx non-invasive, pharmacogenetic test measures, analyzes and interprets the genes of patients with common neuro-psychiatric disorders to predict which drugs are best choices for each specific patient. The test helps to take much of the guesswork out of prescribing medications. 

Brand Thunder formed in April, 2007 to leverage the power of customization within the web browser and offer companies a compelling, patent-pending solution for creating a more persistent presence with their internet consumer. Brand Thunder has branded the browser and extended its functionality for some of the most recognizable brands in sports, music and the internet. Brand Thunder specializes in building custom branded browsers for brand marketers. Give your fans an exciting new look and compelling content for their web browser, and you’ll be rewarded with incremental traffic to your site and increased revenue. These themes appeal to the brand as well as the fan, and it’s easy for both to enjoy a range of benefits.

 
BringShare
 
BringShare was built with small to mid-sized companies in mind, but finds application in businesses small and large that want to better understand and compare all of their marketing data – SEO, social media, email marketing, paid search, Google Analytics and AdWords, display ads and website performance. BringShare puts these individual reports in one master dashboard that mashes everything together in one simplified view so you can compare all of your marketing data and see what really works. (OTAF III)

 
Cardiox Corp.
Cardiox has developed and patented  a non-invasive method for detecting the presence of a right-to-left cardiac shunt to enable closure before the occurrence of a debilitating or life threatening stroke or heart attack.  Pre-clinical animal studies in early 2009 confirmed a sensitivity level of >99%.  The company has now developed a clinical/commercial version of its shunt detection product and is completing clinical trials at several leading hospitals.  The system is simple enough to be performed by a nurse or technician in an office setting.

ClearSaleing Inc., based in Dublin, OH,  is addressing the limitations of currently available systems and leveraging the enormous potential of Pay-Per-Click (PPC) advertising by creating an end-to-end trading and sales system for Internet advertisers. The Clear Saleing system delivers sales effectiveness, ad-spend optimization, enhanced profitability, and lower costs by allowing advertisers to effectively plan, execute, measure, and optimize PPC advertising throughout the sales cycle and across campaigns and search engines.

Ecolibrium Solar, maker of the lightweight Ecofoot and Ecofoot 2 universal mounting systems for solar PV installations, is committed to revolutionizing the solar power market. We design simple, cost effective and ecologically sound products that maximize efficiency and minimize costs – making it easier to implement clean energy technology. After more than year of extensive research and development, what began with a clean sheet of paper evolved into a reinvention of the mounting system. Our research team combines the expertise from the automotive, polymer, construction, and solar industries to create a next-generation family of products that are making solar energy more user-friendly and accessible. Reducing the duration and complexity of solar projects in turn promotes economic advantages and ROI. The skillful design of our products is a progressive step towards reaching our overall goal of grid parity.

 
EndoSphere, Inc.
EndoSphere has developed and will commercialize an innovative device (SatiSphere) designed to treat obesity. SatiSphere’s breakthrough technology offers a safer and more effective solution for significant weight loss without the cost and complications of invasive surgery.